IRC's MS vaccine spurs T-cell response
United Press International - USA
The company said its NeuroVax MS vaccine promotes expression of the so-called FOXP3+ regulatory T-cells that are believed to be key in controlling the ...

The Immune Response Corporation's NeuroVax Restores FOXP3+ T-Cell ...
PharmaLive.com (press release) - Newtown,PA,USA
... BUSINESS WIRE)--Apr 6, 2006 - The Immune Response Corporation (OTCBB:IMNR) announced that its T-cell receptor peptide vaccine candidate, NeuroVax(TM), induces ...

The Immune Response Corporation's NeuroVax(TM) Restores FOXP3+ T ...
International News Service - Sydney,Australia
The Immune Response Corporation (OTCBB:IMNR) announced that its T-cell receptor peptide vaccine candidate, NeuroVax(TM), induces increased FOXP3 expression ...